463 related articles for article (PubMed ID: 31578216)
1. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.
Lidgard B; Zelnickv L; Anderson AH; Feldman H; Go A; He J; Kansal M; Mohanty MJ; Mehta R; Shlipak MG; Soliman E; Weir MR; Bansal N;
Kidney360; 2022 May; 3(5):859-871. PubMed ID: 36128494
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
4. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
5. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
6. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Hyre Anderson A; Yang W; Christenson RH; deFilippi CR; Deo R; Dries DL; Go AS; He J; Kusek JW; Lash JP; Raj D; Rosas S; Wolf M; Zhang X; Shlipak MG; Feldman HI
J Am Soc Nephrol; 2015 Apr; 26(4):946-56. PubMed ID: 25278510
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Bansal N; Zelnick L; Go A; Anderson A; Christenson R; Deo R; Defilippi C; Lash J; He J; Ky B; Seliger S; Soliman E; Shlipak M; ;
J Am Heart Assoc; 2019 Nov; 8(21):e012336. PubMed ID: 31645163
[TBL] [Abstract][Full Text] [Related]
9. Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.
Bansal N; Zelnick LR; Ballantyne CM; Chaves PHM; Christenson RH; Coresh J; deFilippi CR; de Lemos JA; Daniels LB; Go AS; He J; Hedayati SS; Matsushita K; Nambi V; Shlipak MG; Taliercio JJ; Seliger SL;
Am J Kidney Dis; 2022 Mar; 79(3):383-392. PubMed ID: 34293394
[TBL] [Abstract][Full Text] [Related]
10. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
11. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
[TBL] [Abstract][Full Text] [Related]
13. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
14. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
15. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.
Ascher SB; Berry JD; Katz R; de Lemos JA; Bansal N; Garimella PS; Hallan SI; Wettersten N; Jotwani VK; Killeen AA; Ix JH; Shlipak MG
Am J Kidney Dis; 2024 May; 83(5):615-623.e1. PubMed ID: 37992982
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
Spanaus KS; Kronenberg F; Ritz E; Schlapbach R; Fliser D; Hersberger M; Kollerits B; König P; von Eckardstein A;
Clin Chem; 2007 Jul; 53(7):1264-72. PubMed ID: 17478561
[TBL] [Abstract][Full Text] [Related]
17. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
18. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
19. Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.
Vinnakota S; Scott CG; Rodeheffer RJ; Chen HH
Mayo Clin Proc; 2019 Nov; 94(11):2189-2198. PubMed ID: 31668448
[TBL] [Abstract][Full Text] [Related]
20. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
